Objectives

After participating in this educational activity, attendees should be able to:
1| Describe the mechanisms of immune-checkpoint inhibitor-associated thyroid dysfunction and relevant guideline recommendations.

2| Analyze patient-specific clinical presentation and laboratory findings to select appropriate pharmacologic management for decompensated hypothyroidism. 

3| Evaluate the role of adjunctive liothyronine (T3) therapy in decompensated hypothyroidism.

Presenter(s): 
Haley Whelchel, PharmD
PGY1 Pharmacy Resident
Baystate Medical Center
 
NameRoleFinancial Relationship DisclosuresDiscussion of
Unlabeled/Unapproved Uses of
Drugs/Devices in Presentation?
Haley Whelchel, PharmDSpeaker/AuthorNo relevant relationships with ineligible companies to discloseNo
Session date: 
04/13/2026 - 2:00pm to 3:00pm EDT
Location: 
Hybrid
United States
See map: Google Maps
Add to calendar: 
  • 1.00 ACPE Contact Hours
  • 1.00 ACPE Technician contact hours
Please login or register to take this course.